Biorez is a medical device company dedicated to helping patients return to full activity sooner and safer following debilitating ligament and tendon injuries.

Biorez is focused on developing and commercializing regenerative implants related to the orthopedic surgery market.

Biorez was founded in 2008 by Cato T. Laurencin and Joseph W. Reilly. The company is headquartered in New Haven, Connecticut

Biorez has developed the BioBrace™ scaffold, a breakthrough material featuring a highly porous collagen sponge reinforced with bioresorbable microfilaments. The BioBrace implant is intended to augment and reinforce a wide range of tendon and ligament procedures, including rotator cuff repair and ACL reconstruction.

Biorez, through our proprietary open porous architecture, and use of biomaterials, has been engineered to provide a high degree of bio-inductivity to promote rapid tissue regeneration, a biomechanical profile to reinforce repairs throughout the full healing profile, and full absorption overtime to fully restore the anatomy to its normal state.

Biorez is backed by Connecticut Innovations, New York Angels, Pritzker Vlock Family Office, Brainchild Holdings, The Vertical Group and others. The company raised another $3M in a Seed round on Sep 09, 2020 brining the total raised in Seed stage to $7M. This additional investment also brings Biorez's overall total funding to $22.6M to date.